~10 spots leftby Mar 2026

Communities That HEAL Intervention for Opioid Use Disorder

Recruiting in Palo Alto (17 mi)
+3 other locations
Age: Any Age
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: RTI International
No Placebo Group

Trial Summary

What is the purpose of this trial?This study will test the impact of implementing the Communities That Helping to End Addiction Long-term (HEAL) intervention on opioid overdose deaths within 67 highly affected communities with the goal of reducing opioid overdose deaths by 40%.

Eligibility Criteria

The HEALing Communities Study is for communities in Kentucky, Ohio, Massachusetts, or New York that are heavily impacted by opioid overdoses. Eligible communities must have a high rate of opioid-related deaths and be willing to implement strategies like medication-assisted treatment (MOUD), overdose training, and naloxone distribution.

Inclusion Criteria

The community must express willingness to develop partnerships across health care, behavioral health, and justice settings for evidence-based practices to address opioid misuse, OUD, and overdoses
The community must be located in one of the four participating states: Kentucky, Ohio, Massachusetts, or New York
At least 30% of the communities selected within each state must be rural
+2 more

Exclusion Criteria

Communities that did not meet the aforementioned inclusion criteria were excluded from the HCS.

Participant Groups

This study tests the 'Communities That HEAL' intervention aimed at reducing opioid overdose deaths by 40%. Some communities will start the program right away while others will wait to begin. The effectiveness of this community-wide approach on preventing deaths from opioids is being compared.
2Treatment groups
Experimental Treatment
Group I: Wave 2 - Wait-list comparisonExperimental Treatment1 Intervention
Communities in Wave 2 will continue usual care during the first 30 months of the trial. At month 31, Wave 2 communities will begin receiving the CTH intervention.
Group II: Wave 1 - InterventionExperimental Treatment1 Intervention
Communities in Wave 1 will receive the CTH intervention during the first 30 months of the trial. The intervention will include 3 components: community engagement to assist key stakeholders in applying evidence-based practices to addressing their opioid crisis, a menu of evidence-based practices for communities to select and implement, and a communications campaign to build demand for evidence-based practices to address overdose and opioid use disorder.

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
Boston Medical CenterBoston, MA
Ohio State UniversityColumbus, OH
University of KentuckyLexington, KY
Columbia UniversityNew York, NY
Loading ...

Who Is Running the Clinical Trial?

RTI InternationalLead Sponsor
Boston Medical CenterCollaborator
Columbia UniversityCollaborator
University of KentuckyCollaborator
Ohio State UniversityCollaborator
Substance Abuse and Mental Health Services Administration (SAMHSA)Collaborator
National Institute on Drug Abuse (NIDA)Collaborator

References